Houlihan Lokey Cl A saw its IBD SmartSelect Composite Rating rise to 97 Friday, up from 94 the day before.
Lean How — And When — To Sell Stocks
The new rating shows the stock is outpacing 97% of all stocks when it comes to the most important stock-picking criteria. The market's biggest winners often have a 95 or higher rating in the early stages of a new price run, so that's an important benchmark to look for when looking for the best stocks to buy and watch.
Houlihan Lokey Cl A is currently forming a consolidation, with a 192.10 buy point. See if the stock can break out in volume at least 40% higher than normal.
The stock earns a 90 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth tops 90% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
In Q4, the company reported 54% earnings growth. That means it's now posted two straight quarters of rising EPS growth. Sales growth climbed 28%, up from 24% in the prior quarter. That marks two quarters of rising growth.
Houlihan Lokey Cl A holds the No. 3 rank among its peers in the Finance-Investment Banking/Brokers industry group. Futu Holdings ADR is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
